Reply to: 'Rethinking "inactive chronic hepatitis B": should we treat patients with high HBsAg levels?'.

TAI-CHUNG TSENGYang, Hwai-IHwai-IYangJIA-HORNG KAO2026-02-112026-02-112025-09-27https://www.scopus.com/pages/publications/105021586308https://scholars.lib.ntu.edu.tw/handle/123456789/735910enCHRONIC VIRAL HEPATITISHEPATITIS BHEPATOCELLULAR CARCINOMAReply to: 'Rethinking "inactive chronic hepatitis B": should we treat patients with high HBsAg levels?'.letter10.1136/gutjnl-2025-33661841015493